In contrast, the t(9;22) translocation, leading to the BCR::ABL1 fusion gene, is linked to a poor clinical outcome and is more frequently identified in adult BCP-ALL patients. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.